Jorsal A, Wiggers H, Holmager P, Nilsson B, Nielsen R, Boesgaard TW, Kumme A, Mller JE, Videbk L, Kistorp C
Persistent or worsening stomach symptoms after starting semaglutide or tirzepatide warrant immediate contact with your PlexusDx provider
Wilding, J.P.H
On a bell curve, an increase that produces less effect is ambiguous: you cannot tell whether you are below the peak or past it
Clinical trials have shown that patients using semaglutide lose an average of 14.9% of their body weight over 68 weeks
Market Competition Dynamics The projected $15 monthly cost represents the potential endpoint of robust generic competition rather than initial generic pricing